Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Shanghai Fudan Zhangjiang Bio Pharmaceutical Co ( (HK:1349) ) has shared an announcement.
Shanghai Fudan Zhangjiang Bio Pharmaceutical Co has entered into an agreement with Ping An Bank to subscribe to a structured deposit product worth RMB220 million using its idle funds. This transaction is categorized as a disclosable transaction under the Hong Kong Listing Rules, requiring reporting and announcement but exempt from shareholder approval. The structured deposit is principal-guaranteed, linked to gold, and offers a floating return with a medium to low risk level, reflecting the company’s strategic financial management and investment in secure financial products.
More about Shanghai Fudan Zhangjiang Bio Pharmaceutical Co
Average Trading Volume: 18,449,479
Current Market Cap: HK$1.12B
Learn more about 1349 stock on TipRanks’ Stock Analysis page.